{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:23:48Z","timestamp":1787952228646,"version":"build-2784847793"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11894-019-0671-z","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T09:02:44Z","timestamp":1547542964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO)"],"prefix":"10.1007","volume":"21","author":[{"given":"Eamonn M. M.","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"671_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MOG.0000000000000040","volume":"30","author":"EMM Quigley","year":"2014","unstructured":"Quigley EMM. Small intestinal bacterial overgrowth: what it is and what it is not. Curr Opin Gastroenterol. 2014;30:141\u20136.","journal-title":"Curr Opin Gastroenterol"},{"key":"671_CR2","first-page":"1294","volume-title":"Yamada\u2019s textbook of gastroenterology","author":"EMM Quigley","year":"2016","unstructured":"Quigley EMM. Bacterial overgrowth. In: Camilleri M, Fitz JG, Kalloo AN, Podolsky DK, Shanahan F, Wang TC, editors. Yamada\u2019s textbook of gastroenterology. 6th ed. Wiley: Chichester; 2016. p. 1294\u2013304.","edition":"6"},{"key":"671_CR3","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/apt.13622","volume":"43","author":"ER Shanahan","year":"2016","unstructured":"Shanahan ER, Zhong L, Talley NJ, Morrison M, Holtmann G. Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures. Aliment Pharmacol Ther. 2016;43:1186\u201396.","journal-title":"Aliment Pharmacol Ther"},{"key":"671_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13494","volume":"30","author":"M Stefano Di","year":"2018","unstructured":"Di Stefano M, Quigley EMM. The diagnosis of small intestinal bacterial overgrowth: two steps forward, one step backwards? Neurogastroenterol Motil. 2018;30:e13494.","journal-title":"Neurogastroenterol Motil"},{"key":"671_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"\u2022 Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775\u20138 A detailed examination of current criteria for the diagnosis of SIBO together with consensus-based recommendations for the performance and interpretation of breath tests.","journal-title":"Am J Gastroenterol"},{"key":"671_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2009.205476","volume":"60","author":"D Yu","year":"2011","unstructured":"Yu D, Cheesman F, Vanner S. Combined oro-cecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-cecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334\u201340.","journal-title":"Gut"},{"key":"671_CR7","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/ajg.2017.233","volume":"112","author":"W Paterson","year":"2017","unstructured":"Paterson W, Camilleri M, Simren M, Boeckxstaens G, Vanner SJ. Breath testing consensus guidelines for SIBO: RES IPSA LOCQUITOR. Am J Gastroenterol. 2017;112:1888\u20139.","journal-title":"Am J Gastroenterol"},{"key":"671_CR8","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/ajg.2017.373","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Rao S. Response to Paterson et al. Am J Gastroenterol. 2017;112:1889\u201392.","journal-title":"Am J Gastroenterol"},{"key":"671_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cgh.2015.07.032","volume":"124","author":"EC Lin","year":"2016","unstructured":"Lin EC, Massey BT. Scintigraphy demonstrates high rate of false positive results from glucose breath tests for small bowel bacterial overgrowth. Clin Gastroenterol Hepatol. 2016;124:203\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"671_CR10","doi-asserted-by":"publisher","first-page":"e13350","DOI":"10.1111\/nmo.13350","volume":"30","author":"O Sundin","year":"2018","unstructured":"\u2022 Sundin O, Mendoza-Ladd A, Morales E, Fagan BM, Zeng M, Diaz-Arevalo D, et al. Does glucose-based hydrogen and methane breath test detect bacterial overgrowth in the jejunum? Neurogastroenterol Motil. 2018;30:e13350 Questions the validity of glucose- based breath tests.","journal-title":"Neurogastroenterol Motil"},{"key":"671_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrgastro.2017.29","volume":"14","author":"EMM Quigley","year":"2017","unstructured":"Quigley EMM. Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet? Nat Rev Gastroenterol Hepatol. 2017;14:315\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"671_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/apt.14923","volume":"48","author":"KJ Berean","year":"2018","unstructured":"\u2022 Berean KJ, Ha N, Ou JZ, Chrimes AF, Grando D, Yao CK, et al. The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis. Aliment Pharmacol Ther. 2018;48:646\u201354 Pilot data on a very exciting novel technology which provides real time data on intestinal gas production.","journal-title":"Aliment Pharmacol Ther"},{"key":"671_CR13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2017.11.024","volume":"171","author":"P Kundu","year":"2017","unstructured":"Kundu P, Blacher E, Elinav E, Petterson S. Our gut microbiome: the evolving inner self. Cell. 2017;171:1481\u201393.","journal-title":"Cell"},{"key":"671_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-016-0484-6","volume":"16","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis EJ, Pyleris E, Barbatzas C, Pistiki A, Pimentel M. Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. BMC Gastroenterol. 2016;16:67.","journal-title":"BMC Gastroenterol"},{"key":"671_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3748\/wjg.v23.i5.842","volume":"23","author":"T Brechmann","year":"2017","unstructured":"Brechmann T, Sperlbaum A, Schmiegel W. Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: results of a retrospective cohort study. World J Gastroenterol. 2017;23:842\u201352.","journal-title":"World J Gastroenterol"},{"key":"671_CR16","doi-asserted-by":"publisher","DOI":"10.14309\/crj.2018.5","volume":"5","author":"BS Robey","year":"2018","unstructured":"Robey BS, Peery AF, Dellon ES. Small bowel diverticulosis and jejunal perforation in Marfan syndrome. ACG Case Rep J. 2018;5:e5.","journal-title":"ACG Case Rep J"},{"key":"671_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","volume":"53","author":"T Su","year":"2018","unstructured":"Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018;53:27\u201336.","journal-title":"J Gastroenterol"},{"key":"671_CR18","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s10620-017-4726-4","volume":"62","author":"B Chander Roland","year":"2017","unstructured":"Chander Roland B, Mullin GE, Passi M, Zheng X, Salem A, Yolken R, et al. A prospective evaluation of ileocecal valve dysfunction and intestinal motility derangements in small intestinal bacterial overgrowth. Dig Dis Sci. 2017;62:3525\u201335.","journal-title":"Dig Dis Sci"},{"key":"671_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/MCG.0000000000000257","volume":"49","author":"BC Roland","year":"2015","unstructured":"Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, et al. Small intestinal transit time is delayed in small intestinal bacterial overgrowth. J Clin Gastroenterol. 2015;49:571\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"6 Suppl 86","key":"671_CR20","first-page":"S-82-7","volume":"32","author":"M Tauber","year":"2014","unstructured":"Tauber M, Avouac J, Benahmed A, Barbot L, Coustet B, Kahan A, et al. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-82-7.","journal-title":"Clin Exp Rheumatol"},{"key":"671_CR21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","volume":"57","author":"N Pittman","year":"2018","unstructured":"Pittman N, Rawn SM, Wang M, Masetto A, Beattie KA, Larche M. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review. Rheumatology (Oxford). 2018;57:1802\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"671_CR22","doi-asserted-by":"publisher","first-page":"G228","DOI":"10.1152\/ajpgi.00212.2015","volume":"310","author":"E Deloose","year":"2016","unstructured":"Deloose E, Tack J. Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling. Am J Physiol Gastrointest Liver Physiol. 2016;310:G228\u201333.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"671_CR23","doi-asserted-by":"publisher","first-page":"e10554","DOI":"10.1097\/MD.0000000000010554","volume":"97","author":"J Suri","year":"2018","unstructured":"Suri J, Kataria R, Malik Z, Parkman HP, Schey R. Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit. Medicine (Baltimore). 2018;97:e10554.","journal-title":"Medicine (Baltimore)."},{"key":"671_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/QAD.0000000000001802","volume":"32","author":"J Robinson-Papp","year":"2018","unstructured":"Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MC, Sharma S, et al. Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV. AIDS. 2018;32:1147\u201356.","journal-title":"AIDS"},{"key":"671_CR25","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3109\/00365521.2015.1050691","volume":"50","author":"A Greco","year":"2015","unstructured":"Greco A, Caviglia GP, Brignolo P, Ribaldone DG, Reggiani S, Sguazzini C, et al. Glucose breath test and Crohn's disease: diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response. Scand J Gastroenterol. 2015;50:1376\u201381.","journal-title":"Scand J Gastroenterol"},{"key":"671_CR26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MCG.0000000000000803","volume":"52","author":"JERJ Ricci","year":"2018","unstructured":"Ricci JERJ, Chebli LA, Ribeiro TCDR, Castro ACS, Gaburri PD, Pace FHDL, et al. Small-intestinal bacterial overgrowth is associated with concurrent intestinal inflammation but not with systemic inflammation in Crohn\u2019s disease patients. J Clin Gastroenterol. 2018;52:530\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"671_CR27","doi-asserted-by":"crossref","unstructured":"\u2022 Cohen-Mekelburg S, Tafesh Z, Coburn E, Weg R, Malik N, Webb C, Hammad H, Scherl E, Bosworth BP. Testing and treating small intestinal bacterial overgrowth reduces symptoms in patients with inflammatory bowel disease. Dig Dis Sci. 2018. Emphasizes the need to consider SIBO in the symptomatic IBD patient.","DOI":"10.1007\/s10620-018-5109-1"},{"key":"671_CR28","doi-asserted-by":"crossref","unstructured":"Losurdo G, Marra A, Shahini E, Girardi B, Giorgio F, Amoruso A, et al. Small intestinal bacterial overgrowth and celiac disease: a systematic review with pooled-data analysis. Neurogastroenterol Motil. 2017;29.","DOI":"10.1111\/nmo.13028"},{"key":"671_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/2050640616630117","volume":"4","author":"G Capurso","year":"2016","unstructured":"\u2022 Capurso G, Signoretti M, Archibugi L, Stigliano S, Delle FG. Systematic review and meta-analysis: small intestinal bacterial overgrowth in chronic pancreatitis. United European Gastroenterol J. 2016;4:697\u2013705 Describes the prevalence of and risk factors for SIBO in chronic pancreatitis.","journal-title":"United European Gastroenterol J"},{"key":"671_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.pan.2018.02.010","volume":"18","author":"HM N\u00ed Chonchubhair","year":"2018","unstructured":"N\u00ed Chonchubhair HM, Bashir Y, Dobson M, Ryan BM, Duggan SN, Conlon KC. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology. 2018;18:379\u201385.","journal-title":"Pancreatology"},{"key":"671_CR31","first-page":"7424831","volume":"2016","author":"A Therrien","year":"2016","unstructured":"Therrien A, Bouchard S, Sidani S, Bouin M. Prevalence of small intestinal bacterial overgrowth among chronic pancreatitis patients: a case-control study. Can J Gastroenterol Hepatol. 2016;2016:7424831.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"671_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.pan.2015.07.005","volume":"15","author":"DB Kim","year":"2015","unstructured":"Kim DB, Paik CN, Sung HJ, Chung WC, Lee KM, Yang JM, et al. Breath hydrogen and methane are associated with intestinal symptoms in patients with chronic pancreatitis. Pancreatology. 2015;15:514\u20138.","journal-title":"Pancreatology"},{"key":"671_CR33","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.3748\/wjg.v23.i48.8591","volume":"23","author":"M Zhang","year":"2017","unstructured":"Zhang M, Zhu HM, He F, Li BY, Li XC. Association between acute pancreatitis and small intestinal bacterial overgrowth assessed by hydrogen breath test. World J Gastroenterol. 2017;23:8591\u20136.","journal-title":"World J Gastroenterol"},{"key":"671_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0037-1608832","volume":"37","author":"A Shah","year":"2017","unstructured":"\u2022 Shah A, Shanahan E, Macdonald GA, Fletcher L, Ghasemi P, Morrison M, et al. Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in chronic liver disease. Semin Liver Dis. 2017;37:388\u2013400 Reaffirms, within the limits of diagnostic methodology, the association between SIBO and chronic liver disease.","journal-title":"Semin Liver Dis"},{"key":"671_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5114\/aoms.2015.55675","volume":"12","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Feng Y, Cao B, Tian Q. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. Arch Med Sci. 2016;12:592\u20136.","journal-title":"Arch Med Sci"},{"key":"671_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0036-1593879","volume":"36","author":"DW Victor 3rd","year":"2016","unstructured":"Victor DW 3rd, Quigley EM. The microbiome and the liver: the basics. Semin Liver Dis. 2016;36:299\u2013305.","journal-title":"Semin Liver Dis"},{"key":"671_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1055\/s-0036-1593880","volume":"36","author":"EM Quigley","year":"2016","unstructured":"Quigley EM, Abu-Shanab A, Murphy EF, Stanton C, Monsour HP Jr. The metabolic role of the microbiome: implications for NAFLD and the metabolic syndrome. Semin Liver Dis. 2016;36:312\u20136.","journal-title":"Semin Liver Dis"},{"key":"671_CR38","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.numecd.2016.04.007","volume":"26","author":"A Fialho","year":"2016","unstructured":"Fialho A, Fialho A, Thota P, McCullough A, Shen B. Higher visceral to subcutaneous fat ratio is associated with small intestinal bacterial overgrowth. Nutr Metab Cardiovasc Dis. 2016;26:773\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"671_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11695-016-2343-5","volume":"27","author":"JM Sabate","year":"2017","unstructured":"Sabate JM, Coupaye M, Ledoux S, Castel B, Msika S, Coffin B, et al. Consequences of small intestinal bacterial overgrowth in obese patients before and after bariatric surgery. Obes Surg. 2017;27:599\u2013605.","journal-title":"Obes Surg"},{"key":"671_CR40","doi-asserted-by":"crossref","unstructured":"Roland BC, Lee D, Miller LS, Vegesna A, Yolken R, Severance E, et al. Obesity increases the risk of small intestinal bacterial overgrowth (SIBO). Neurogastroenterol Motil. 2018;30.","DOI":"10.1111\/nmo.13199"},{"key":"671_CR41","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1515\/jpem-2017-0252","volume":"30","author":"O Belei","year":"2017","unstructured":"Belei O, Olariu L, Dobrescu A, Marcovici T, Marginean O. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents. J Pediatr Endocrinol Metab. 2017;30:1161\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"671_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12291-016-0569-6","volume":"32","author":"SV Rana","year":"2017","unstructured":"Rana SV, Malik A, Bhadada SK, Sachdeva N, Morya RK, Sharma G. Malabsorption, orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetic patients: a connection. Indian J Clin Biochem. 2017;32:84\u20139.","journal-title":"Indian J Clin Biochem"},{"key":"671_CR43","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12664-017-0797-6","volume":"36","author":"UC Ghoshal","year":"2017","unstructured":"Ghoshal UC, Baba CS, Ghoshal U, Alexander G, Misra A, Saraswat VA, et al. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. Indian J Gastroenterol. 2017;36:390\u20139.","journal-title":"Indian J Gastroenterol"},{"key":"671_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jgh.13058","volume":"31","author":"S Kapil","year":"2016","unstructured":"Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, et al. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2016;31:213\u201321.","journal-title":"J Gastroenterol Hepatol"},{"key":"671_CR45","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3346\/jkms.2017.32.6.948","volume":"32","author":"SE Jung","year":"2017","unstructured":"Jung SE, Joo NS, Han KS, Kim KN. Obesity is inversely related to hydrogen-producing small intestinal bacterial overgrowth in non-constipation irritable bowel syndrome. J Korean Med Sci. 2017;32:948\u201353.","journal-title":"J Korean Med Sci"},{"key":"671_CR46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10620-017-4828-z","volume":"63","author":"A Fialho","year":"2018","unstructured":"Fialho A, Fialho A, Kochhar G, Schenone AL, Thota P, McCullough AJ, et al. Association between small intestinal bacterial overgrowth by glucose breath test and coronary artery disease. Dig Dis Sci. 2018;63:412\u201321.","journal-title":"Dig Dis Sci"},{"key":"671_CR47","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3748\/wjg.v23.i7.1241","volume":"23","author":"FR Ponziani","year":"2017","unstructured":"Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol. 2017 Feb;23:1241\u20139.","journal-title":"World J Gastroenterol"},{"key":"671_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EMM Quigley","year":"2017","unstructured":"Quigley EMM. Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep. 2017;17:94.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"671_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","volume":"20","author":"AH Tan","year":"2014","unstructured":"Tan AH, Mahadeva S, Thalha AM, Gibson PR, Kiew CK, Yeat CM, et al. Small intestinal bacterial overgrowth in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20:535\u201340.","journal-title":"Parkinsonism Relat Disord"},{"key":"671_CR50","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00702-016-1612-8","volume":"123","author":"XL Niu","year":"2016","unstructured":"Niu XL, Liu L, Song ZX, Li Q, Wang ZH, Zhang JL, et al. Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson\u2019s disease. J Neural Transm (Vienna). 2016;123:1381\u20136.","journal-title":"J Neural Transm (Vienna)"},{"key":"671_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.parkreldis.2018.04.003","volume":"54","author":"JA Vizcarra","year":"2018","unstructured":"Vizcarra JA, Wilson-Perez HE, Fasano A, Espay AJ. Small intestinal bacterial overgrowth in Parkinson\u2019s disease: tribulations of a trial. Parkinsonism Relat Disord. 2018;54:110\u20132.","journal-title":"Parkinsonism Relat Disord"},{"key":"671_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jneuroim.2016.11.004","volume":"301","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Liu G, Duan Y, Han X, Dong H, Geng J. Prevalence of small intestinal bacterial overgrowth in multiple sclerosis: a case-control study from China. J Neuroimmunol. 2016;301:83\u20137.","journal-title":"J Neuroimmunol"},{"key":"671_CR53","doi-asserted-by":"publisher","first-page":"e02102","DOI":"10.1128\/mBio.02102-15","volume":"7","author":"JR Donowitz","year":"2016","unstructured":"\u2022 Donowitz JR, Haque R, Kirkpatrick BD, Alam M, Lu M, Kabir M, et al. Small intestine bacterial overgrowth and environmental enteropathy in Bangladeshi children. MBio. 2016;7:e02102\u201315 Describes the prevalence and nutritional implications of SIBO in an at-risk population.","journal-title":"MBio"},{"key":"671_CR54","first-page":"299","volume":"4","author":"A Fialho","year":"2016","unstructured":"Fialho A, Fialho A, Schenone A, Thota P, McCullough A, Shen B. Association between small intestinal bacterial overgrowth and deep vein thrombosis. Gastroenterol Rep (Oxf). 2016;4:299\u2013303.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"671_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clinbiochem.2016.08.017","volume":"50","author":"D Enko","year":"2017","unstructured":"Enko D, Kriegsh\u00e4user G. Functional 13C-urea and glucose hydrogen\/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori infection. Clin Biochem. 2017;50:46\u20139.","journal-title":"Clin Biochem"},{"key":"671_CR56","doi-asserted-by":"publisher","first-page":"7461426","DOI":"10.1155\/2017\/7461426","volume":"2017","author":"E Verrecchia","year":"2017","unstructured":"Verrecchia E, Sicignano LL, La Regina M, Nucera G, Patisso I, Cerrito L, et al. Small intestinal bacterial overgrowth affects the responsiveness to colchicine in familial Mediterranean fever. Mediat Inflamm. 2017;2017:7461426.","journal-title":"Mediat Inflamm"},{"key":"671_CR57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/jgh.14113","volume":"33","author":"DB Kim","year":"2018","unstructured":"Kim DB, Paik CN, Song DS, Kim YJ, Lee JM. The characteristics of small intestinal bacterial overgrowth in patients with gallstone diseases. J Gastroenterol Hepatol. 2018;33:1477\u201384.","journal-title":"J Gastroenterol Hepatol"},{"key":"671_CR58","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3892\/mco.2016.807","volume":"4","author":"L Deng","year":"2016","unstructured":"Deng L, Liu Y, Zhang D, Li Y, Xu L. Prevalence and treatment of small intestinal bacterial overgrowth in postoperative patients with colorectal cancer. Mol Clin Oncol. 2016;4:883\u20137.","journal-title":"Mol Clin Oncol"},{"key":"671_CR59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41424-018-0011-x","volume":"9","author":"SSC Rao","year":"2018","unstructured":"Rao SSC, Tan G, Abdulla H, Yu S, Larion S, Leelasinjaroen P. Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)? Clin Transl Gastroenterol. 2018;9:146.","journal-title":"Clin Transl Gastroenterol"},{"key":"671_CR60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5056\/jnm15080","volume":"21","author":"HJ Jung","year":"2015","unstructured":"Jung HJ, Paik CN, Chung WC, Lee KM, Yang JM, Choi MG. Small intestinal bacterial overgrowth diagnosed by glucose hydrogen breath test in post-cholecystectomy patients. J Neurogastroenterol Motil. 2015;21:545\u201351.","journal-title":"J Neurogastroenterol Motil"},{"key":"671_CR61","doi-asserted-by":"publisher","unstructured":"\u2022 Chen B, Kim JJ, Zhang Y, Du L, Dai N. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol. 2018. https:\/\/doi.org\/10.1007\/s00535-018-1476-9 . The latest systematic review on this controversial topic.","DOI":"10.1007\/s00535-018-1476-9"},{"key":"671_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-016-0484-6","volume":"16","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis EJ, Pyleris E, Barbatzas C, Pistiki A, Pimentel M. Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. BMC Gastroenterol. 2016 Jul;16:67.","journal-title":"BMC Gastroenterol"},{"key":"671_CR63","first-page":"3230859","volume":"2016","author":"H Chu","year":"2016","unstructured":"Chu H, Fox M, Zheng X, Deng Y, Long Y, Huang Z, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome: clinical characteristics, psychological factors, and peripheral cytokines. Gastroenterol Res Pract. 2016;2016:3230859.","journal-title":"Gastroenterol Res Pract"},{"key":"671_CR64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.14423\/SMJ.0000000000000454","volume":"109","author":"SK Long","year":"2016","unstructured":"Long SK, Di Palma JA. Does carbohydrate challenge testing predict clinical response in small intestinal bacterial overgrowth? South Med J. 2016;109:296\u20139.","journal-title":"South Med J"},{"key":"671_CR65","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/MEG.0000000000000557","volume":"28","author":"UC Ghoshal","year":"2016","unstructured":"Ghoshal UC, Srivastava D, Misra A, Ghoshal U. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2016;28:281\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"671_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.32","volume":"7","author":"A Acosta","year":"2016","unstructured":"Acosta A, Camilleri M, Shin A, Linker Nord S, O'Neill J, Gray AV, et al. Effects of rifaximin on transit, permeability, fecal microbiome, and organic acid excretion in irritable bowel syndrome. Clin Transl Gastroenterol. 2016;7:e173.","journal-title":"Clin Transl Gastroenterol"},{"key":"671_CR67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrgastro.2017.37","volume":"14","author":"UC Ghoshal","year":"2017","unstructured":"\u2022 Ghoshal UC, Gwee KA. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol. 2017;14:435\u201341 Interesting discussion on the relationships between these disorders, proposing SIBO as the common factor.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"671_CR68","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MOG.0000000000000348","volume":"33","author":"I Aziz","year":"2017","unstructured":"\u2022 Aziz I, T\u00f6rnblom H, Simr\u00e9n M. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty? Curr Opin Gastroenterol. 2017;33:196\u2013202 A carefully argued critical review of the status of the SIBO-IBS relationship.","journal-title":"Curr Opin Gastroenterol"},{"key":"671_CR69","first-page":"283","volume":"25","author":"J Yao","year":"2016","unstructured":"Yao J, Chang L, Yuan L, Duan Z. Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis. Asia Pac J Clin Nutr. 2016;25:283\u201391.","journal-title":"Asia Pac J Clin Nutr"},{"key":"671_CR70","doi-asserted-by":"publisher","unstructured":"Oliveira RB, Martinelli ALC, Troncon LEA, Elias J Jr. Small intestinal bacterial overgrowth (SIBO) and vitamin K-responsive coagulopathy: a previously unrecorded association. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2017-223531 .","DOI":"10.1136\/bcr-2017-223531"},{"key":"671_CR71","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/jth.13583","volume":"15","author":"X Cheng","year":"2017","unstructured":"Cheng X, Zhang L, Xie NC, Xu HL, Lian YJ. Association between small-intestinal bacterial overgrowth and deep vein thrombosis in patients with spinal cord injuries. J Thromb Haemost. 2017;15:304\u201311.","journal-title":"J Thromb Haemost"},{"key":"671_CR72","doi-asserted-by":"publisher","unstructured":"McIntosh S, Medjoub K, Deans K, Sexton S. Hyperammonaemic encephalopathy following an uncomplicated surgery. BMJ Case Rep 2017. https:\/\/doi.org\/10.1136\/bcr-2017-221458 .","DOI":"10.1136\/bcr-2017-221458"},{"key":"671_CR73","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","volume":"45","author":"L Gatta","year":"2017","unstructured":"Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45:604\u201316.","journal-title":"Aliment Pharmacol Ther"},{"key":"671_CR74","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","volume":"51","author":"C Zhong","year":"2017","unstructured":"Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence. J Clin Gastroenterol. 2017;51:300\u201311.","journal-title":"J Clin Gastroenterol"},{"key":"671_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gtc.2017.09.008","volume":"47","author":"A Adike","year":"2018","unstructured":"\u2022 Adike A, DiBaise JK. Small intestinal bacterial overgrowth: nutritional implications, diagnosis, and management. Gastroenterol Clin N Am. 2018;47:193\u2013208 An up-to-date review of SIBO management.","journal-title":"Gastroenterol Clin N Am"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-019-0671-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-019-0671-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-019-0671-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T14:22:45Z","timestamp":1606054965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-019-0671-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1007\/s11894-019-0671-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"15 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Eamonn M M Quigley reports consultancies with and\/or research support from 4D Pharma, Alimentary Health, Allergan, Axon Pharma, Biocodex, Glycyx, Ironwood, Pharmasierra, Salix, Shire, Takeda, Vibrant, and Zeeland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"3"}}